Key Insights:
- Regional Analysis: Gain insights into the U.S. market, estimated at $285.8 Million in 2023, and China, forecasted to grow at an impressive 15.9% CAGR to reach $534.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Amyotrophic Lateral Sclerosis Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Amyotrophic Lateral Sclerosis Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Amyotrophic Lateral Sclerosis Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as AB Science SA, Apotex, Inc., Aquestive, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 23 Featured):
- AB Science SA
- Apotex, Inc.
- Aquestive
- Biogen, Inc.
- Brainstorm Cell Therapeutics Inc.
- Cytokinetics, Inc.
- F. Hoffmann-La Roche AG
- Genervon Biopharmaceuticals LLC
- Ionis Pharmaceuticals, Inc.
- Kringle Pharma Inc.
- Mitsubishi Tanabe Pharma Corporation
- Neuralstem, Inc.
- Orion Corporation
- Orphazyme A/S
- Sanofi SA
- Treeway BV
- Valeant Pharmaceuticals International, Inc.
- ViroMed Co., Ltd.
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AB Science SA
- Apotex, Inc.
- Aquestive
- Biogen, Inc.
- Brainstorm Cell Therapeutics Inc.
- Cytokinetics, Inc.
- F. Hoffmann-La Roche AG
- Genervon Biopharmaceuticals LLC
- Ionis Pharmaceuticals, Inc.
- Kringle Pharma Inc.
- Mitsubishi Tanabe Pharma Corporation
- Neuralstem, Inc.
- Orion Corporation
- Orphazyme A/S
- Sanofi SA
- Treeway BV
- Valeant Pharmaceuticals International, Inc.
- ViroMed Co., Ltd.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 183 |
Published | April 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 923.5 Million |
Forecasted Market Value ( USD | $ 3200 Million |
Compound Annual Growth Rate | 16.7% |
Regions Covered | Global |